Home
News
- 1 GE Healthcare Technologies (NASDAQ: GEHC) stock lost 11% of its trading price on August 11.
- 2 GEHC’s share price surged approximately 17% Year-to-Date (YTD).
- 3 In 52 weeks, GEHC’s highest price was $87.83, and the lowest price was $53.
NASDAQ: GEHC stock shedd $4.58 over the week. On August 11, GEHC opened at $72.14. It lowered at $70.86 and hit a high of $72.14. The stock closed at $71.59 with intraday trading volume of 2.898 Million.
In the 52-weeks time frame, GEHC stock’s highest traded price was $87.83, and its lowest traded price was $53. The annual price target for GEHC stock is $89.89, around 25.56% greater than its current trading price.
GEHC’s stock price lost more than 11% monthly and declined over 4.41% in a quarter. Despite these declines, GE Healthcare Technologies’ stock price surged over 17.98% Year-to-Date (YTD).
GE Healthcare Technologies’ market capitalization is $32.562 Billion, and its average trading volume is 2.647 Million.
GEHC Stock Price Analysis
Over the past two trading sessions, sellers have seemed more aggressive than buyers, dragging GEHC stock price down over 3% in the past two days. There are possibilities that GEHC share price could decline on Monday. The immediate support is $70.02 and the next possible support of $68.50.
If sellers fail to sustain their positions, GEHC stock price might bounce and face resistance at $74.88 followed by $78.32. The recent decline suggests bearishness (mid to long term).
A surge might be seen once stock bypasses 50- and 200-day EMAs. TradingView shows 392.027 Million GEHC shares are free-floating, and 62.781 Million shares are closely held by the company’s financial backers or the board of directors.
Ge Healthcare Technologies Earnings & Revenue
In Q1 2023, the company was expected to report $4.63 Billion in revenue, but reported $4.71 Billion in revenue. Similarly, in Q2, the estimated revenue was $4.79 Billion; however, the reported revenue was $4.82 Billion.
For Q3, the company’s estimated revenue was $4.81 Billion, and in the last quarter, analysts believed it could report $5.15 Billion. Earnings per share surged over 7.26% in Q1 and around 5.85% in Q2.
In the financial year 2022, Ge Healthcare Technologies reported $18.34 Billion in revenue, which constitutes 39% gross profit, 17% earnings before interest, taxes, depreciation, and amortization (EBITDA), 14% earnings before interest and taxes (EBIT) and 10% net income.
Technical Levels
Resistance Levels: $74.88 and $78.32
Support Levels: $70.02 and $68.50
Conclusion
Downtrends and uptrends are part of the trading ecosystem. The recent decline in GEHC stock price is like a tiny cloud that vanishes after rain. There are possibilities that bearishness might end soon and the stock price might show impressive upper movement by the end of the coming week.
Disclaimer
The views and opinions stated by the author, or any people named in this article, are for informational ideas only and do not establish financial, investment, or other advice. Investing in or trading crypto assets comes with a risk of financial loss.
Steve Anderson is an Australian crypto enthusiast. He is a specialist in management and trading for over 5 years. Steve has worked as a crypto trader, he loves learning about decentralisation, understanding the true potential of the blockchain.
